Covalon receives Canadian patent for drug delivery via therapeutic hydrogels

The company said that the technology can be used for site-specific delivery of several drugs in a time-release fashion from combination medical devices. The patent reportedly augments and strengthens Covalon’s technology position in the expanding area of combination medical devices.

According to Covalon, the devices that may benefit from the technology include implantable medical devices, wound closure systems and wound dressings that can contain a variety of active agents such as antibiotics, hormones, growth factors and other therapeutics that are beneficial for the medical condition under management.